共 48 条
- [1] Heart and stroke facts, (1994)
- [2] Wilcox, Von der Lippe, Olsson, Jensen, Skene, Hampton, Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction, Lancet, 334, 2, pp. 525-530, (1988)
- [3] GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico., Lancet, 336, pp. 65-71, (1990)
- [4] International Study of Infarct Survival (ISIS-3), A randomized comparison of plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction, Lancet, 339, pp. 753-770, (1993)
- [5] Simoons, Serruys, van den Brand, Et al., Improved survival after early thrombolysis in acute myocardial infarction, Lancet, 8455, 2, pp. 578-582, (1985)
- [6] Dracup, Moser, Treatment-seeking behavior among those with signs and symptoms of acute myocardial infarction, Heart Lung, 20, pp. 570-575, (1991)
- [7] Moser, Dracup, Gender differences in treatment-seeking delay in acute myocardial infarction, Prog Cardiovasc Nurs, 8, pp. 6-12, (1993)
- [8] Turi, Stone, Muller, Et al., Implications for acute intervention related to time of hospital arrival in acute myocardial infarction, Am J Cardiol, 58, pp. 203-209, (1986)
- [9] Meischke, Eisenberg, Larsen, Prehospital delay interval for patients who use emergency medical services: The effect of heart-related medical conditions and demographic variables, Annals of Emergency Medicine, 22, pp. 1597-1601, (1992)
- [10] Ghali, Cooper, Kowatly, Liao, Delay between onset of chest pain and arrival to the coronary care unit among minority and disadvantaged patients, J Nat Med Assoc, 85, pp. 180-184, (1993)